Haleon (HLN) Other Operating Expenses (2021 - 2025)

Haleon's (HLN) quarterly Other Operating Expenses came in at $4.0 million in Q4 2025, up 164.77% on a QoQ basis from -$6.2 million in Q4 2023.

Haleon (HLN) Other Operating Expenses (2021 - 2025) Analysis & Trends

Haleon (HLN) has 4 years of Other Operating Expenses data on file, last reported at $4.0 million in Q4 2025.

Quarterly Other Operating Expenses changed N/A year-over-year to $4.0 million in Q4 2025, while the trailing twelve-month figure through Jun 2026 was $4.0 million (changed N/A YoY) and the FY2025 annual result came in at $16.0 million, down 90.54% from the prior year.
Other Operating Expenses grew to $4.0 million in Q4 2025, from -$6.2 million in the prior quarter.
In the past five years, Other Operating Expenses ranged from a high of $37.5 million in Q4 2022 to a low of -$6.2 million in Q4 2023.
A 4-year average of $8.9 million and a median of $4.0 million in 2025 frame the typical range for Other Operating Expenses.
Annual changes were most pronounced in 2022 — Other Operating Expenses soared 32.59% — and 2023, when it sank 116.53%.
Tracing HLN's Other Operating Expenses over 4 years: stood at $28.3 million in 2021, then jumped by 32.59% to $37.5 million in 2022, then sank by 116.53% to -$6.2 million in 2023, then surged by 164.77% to $4.0 million in 2025.
The last three Other Operating Expenses figures came in at $4.0 million (Q4 2025), -$6.2 million (Q4 2023), and -$2.5 million (Q2 2023), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.85 Bn	42.88 Bn	-
2	Teva Pharmaceutical Industries	43.31 Bn	39.66 Bn	2.15 Bn
3	Zoetis	31.65 Bn	29.98 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.68 Bn	22.88 Bn	5.10 Bn
5	United Therapeutics	22.18 Bn	19.52 Bn	683.80 Mn
6	Viatris	18.82 Bn	17.94 Bn	1.46 Bn
7	Neurocrine Biosciences	15.70 Bn	15.31 Bn	935.80 Mn
8	Elanco Animal Health	12.11 Bn	11.58 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.13 Bn	9.96 Bn	-
10	Alkermes	8.21 Bn	7.55 Bn	397.90 Mn

Download Data